HUTCHMED (China) (HCM) Assets (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Assets came in at $225.4 million in Q4 2025, up 37.53% year-on-year from $163.9 million in Q4 2024, and down 87.31% on a QoQ basis from $1.8 billion in Q2 2025.
HUTCHMED (China) (HCM) Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Assets data on file, last reported at $225.4 million in Q4 2025.
- On a quarterly basis, Assets rose 37.53% year-over-year to $225.4 million in Q4 2025; TTM through Dec 2025 was $225.4 million, a 37.53% increase from a year earlier, with the FY2025 full-year figure at $225.4 million, up 38.03% from the prior year.
- Assets for Q4 2025 stood at $225.4 million, down from $1.8 billion in the prior quarter.
- Over the last five years, Assets for HCM reached as high as $1.8 billion in Q2 2025 and fell as low as $163786.0 in Q4 2023.
- Historically, Assets has averaged $744.7 million across 5 years, with a median of $693.1 million in 2021.
- Across the five-year window, Assets plunged 99.88% in 2023 and soared 99970.22% in 2024, its largest moves.
- Year by year, Assets stood at $176.2 million in 2021, then slipped by 25.32% to $131.6 million in 2022, then sank by 99.88% to $163786.0 in 2023, then surged by 99970.22% to $163.9 million in 2024, then soared by 37.53% to $225.4 million in 2025.
- Per Business Quant data, the three most recent Assets figures were $225.4 million in Q4 2025, $1.8 billion in Q2 2025, and $163.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 225.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 225.41 Mn |
| Jun 30, 2025 | 1.78 Bn |
| Dec 31, 2024 | 163.90 Mn |
| Jun 30, 2024 | 1.26 Bn |
| Dec 31, 2023 | 163,786.01 |
| Jun 30, 2023 | 1.30 Bn |
| Dec 31, 2022 | 131.60 Mn |
| Jun 30, 2022 | 1.19 Bn |
| Dec 31, 2021 | 176.22 Mn |
| Jun 30, 2021 | 1.27 Bn |
| Mar 31, 2021 | 693.12 Mn |
| Dec 31, 2020 | 624.10 Mn |
| Jun 30, 2020 | 525.56 Mn |
| Dec 31, 2019 | 412.12 Mn |
| Sep 30, 2019 | 454.09 Mn |
| Jun 30, 2019 | 495.21 Mn |
| Mar 31, 2019 | 539.30 Mn |
| Dec 31, 2018 | 532.12 Mn |
| Jun 30, 2018 | 577.94 Mn |
| Dec 31, 2017 | 597.93 Mn |